PolyPeptide Group AG (0AAJ.L) LSE
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
PolyPeptide Group AG
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1362
First IPO Date
November 12, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Juan Jose Gonzalez | Chief Executive Officer | 1.7M | 1972 |
| Andreas Liese | Corporate Compliance Manager | 0 | N/A |
| Monika Casanova | Chief Human Resources Officer | 0 | 1979 |
| Michael Staheli | Head of Investor Relations & Corporate Communications | 0 | 1965 |
| Olivier Ludemann-Hombourger | Director of Global Innovation & Technology | 0 | 1972 |
| Christophe Chevalier | Head of Technical Department - Braine | 0 | N/A |
| Trishul Shah | Interim Director Global Sales & Marketing | 0 | N/A |
| Tim Brandl | Interim CFO and Director of Investor Relations, Financial Planning & Analysis | 0 | N/A |
| Christina Del Vecchio | Chief Legal Officer & Corporate Secretary | 0 | 1978 |
| Rene Vestergaard | Director of Corporate Finance | 0 | N/A |
Description
Operating globally, PolyPeptide Group AG functions as a prominent contract development and manufacturing organization (CDMO). The company specializes in producing both proprietary and generic GMP-certified peptides, which are supplied to pharmaceutical and biotechnology firms. These crucial components are integrated into approved pharmaceutical products, drugs in various stages of clinical development, and generic medications. PolyPeptide Group also handles the manufacturing of bespoke research-grade peptides and is engaged in the development of neoantigen peptides designed to advance personalized cancer therapies. Its services further encompass the production of peptides for commercially available peptide therapeutics, as well as the creation of peptide-based generics for both human and animal health sectors, alongside peptides for the cosmetics industry. Additionally, the company offers vital regulatory affairs assistance. Established in 1952, PolyPeptide Group AG maintains its corporate headquarters in Zug, Switzerland, and operates as a subsidiary of Draupnir Holding B.V.
